Literature DB >> 9281463

Allergen source materials and quality control of allergenic extracts.

R E Esch1.   

Abstract

Allergen extracts are prepared from a wide variety of source materials including pollens, fungi, arthropods, animal danders, foods, and dusts. The composition of allergen extracts can vary depending on the allergen source, manufacturing process, and storage conditions. Allergen-specific immunoglobulin E (IgE) assays and skin tests employ a variety of allergen-containing reagents that confer specificity on the test. Given that the allergen source materials are heterogenous mixtures of proteins, glycoproteins, carbohydrates, and other substances that are not allergenic, it is not unexpected that variability exists between test results obtained with different allergen-containing reagents. Variability within a single manufacturer's allergen product can be controlled by using reproducible extraction and processing procedures, single large lots of allergen source materials, and solid-phase supports. These controls do not, however, ensure the consistency of products between manufacturers or laboratories because allergen source materials, manufacturing procedures, and acceptance criteria for allergen reagents may vary.

Mesh:

Substances:

Year:  1997        PMID: 9281463     DOI: 10.1006/meth.1997.0491

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  10 in total

Review 1.  Laboratory methods for allergen extract analysis and quality control.

Authors:  T J Grier
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

Review 2.  Standardization and Regulation of Allergen Products in the European Union.

Authors:  Julia Zimmer; Stefan Vieths; Susanne Kaul
Journal:  Curr Allergy Asthma Rep       Date:  2016-03       Impact factor: 4.806

Review 3.  Evaluation of allergen vaccine potency.

Authors:  Robert E Esch
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

4.  Definition of a pool of epitopes that recapitulates the T cell reactivity against major house dust mite allergens.

Authors:  D Hinz; C Oseroff; J Pham; J Sidney; B Peters; A Sette
Journal:  Clin Exp Allergy       Date:  2015-10       Impact factor: 5.018

5.  The anti-vaccination movement and resistance to allergen-immunotherapy: a guide for clinical allergists.

Authors:  Jason Behrmann
Journal:  Allergy Asthma Clin Immunol       Date:  2010-09-15       Impact factor: 3.406

6.  Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts.

Authors:  Anne Casset; Adriano Mari; Ashok Purohit; Yvonne Resch; Margit Weghofer; Rosetta Ferrara; Wayne R Thomas; Claudia Alessandri; Kuan-Wei Chen; Frédéric de Blay; Rudolf Valenta; Susanne Vrtala
Journal:  Int Arch Allergy Immunol       Date:  2012-06-21       Impact factor: 2.749

7.  IgE Cross-Reactivity between Humulus japonicus and Humulus lupulus.

Authors:  Kyoung Yong Jeong; Jongsun Lee; Gianni Mistrello; Kyung Hee Park; Jung Won Park
Journal:  Yonsei Med J       Date:  2018-09       Impact factor: 2.759

Review 8.  Global View on Ant Venom Allergy: from Allergenic Components to Clinical Management.

Authors:  Troy Wanandy; Emily Mulcahy; Wun Yee Lau; Simon G A Brown; Michael D Wiese
Journal:  Clin Rev Allergy Immunol       Date:  2021-06-01       Impact factor: 8.667

9.  Dual function of novel pollen coat (surface) proteins: IgE-binding capacity and proteolytic activity disrupting the airway epithelial barrier.

Authors:  Mohamed Elfatih H Bashir; Jason M Ward; Matthew Cummings; Eltayeb E Karrar; Michael Root; Abu Bekr A Mohamed; Robert M Naclerio; Daphne Preuss
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

10.  Looking ahead at the potential benefits of biotechnology-derived allergen therapeutics.

Authors:  Jason Behrmann
Journal:  Clin Mol Allergy       Date:  2007-07-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.